| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.083 | 0.5 |